ARACELY ALVAREZ: Open Payments
NPI 1417556721 · BOAZ, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 26 payments from 13 companies in 2025. Trend: 2023 $1,226 · 2024 $1,088 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Exact Sciences Corporation | 4 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Indivior Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: Kerendia, RECORLEV, Cologuard Collection Kit, FANAPT, AIRSUPRA, SUBLOCADE, BREZTRI, REXULTI.
Industry payments across AL — which companies pay providers there.
